Syros Pharmaceuticals Inc...
(SYRS) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.26
-0.50%
Pre-market Jan 07, 2025, 05:02 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 139.53M | 167.47M | 92.30M | 173.98M | 41.44M | 49.89M | 32.20M | 58.59M | 35.91M | 60.39M | 3.80M |
Short-Term Investments | n/a | 34.84M | 38.07M | n/a | 49.98M | 49.79M | 39.84M | 25.00M | n/a | n/a | n/a |
Long-Term Investments | n/a | 3.09M | 13.04M | 3.09M | 3.09M | 290.00K | 290.00K | 483.00K | 483.00K | n/a | n/a |
Other Long-Term Assets | 3.71M | 5.35M | 6.03M | 1.97M | 490.00K | 881.00K | 1.10M | 482.00K | 1.90M | 70.00K | 70.00K |
Receivables | n/a | 1.69M | 2.98M | 2.33M | 20.16M | n/a | n/a | 867.00K | n/a | n/a | n/a |
Inventory | n/a | 1.00 | n/a | 1.00 | 290.00K | n/a | n/a | 1.00 | n/a | n/a | n/a |
Other Current Assets | 5.45M | 7.39M | 3.24M | 2.24M | 2.94M | 2.06M | 1.11M | 2.10M | 540.00K | 150.00K | 112.00K |
Total Current Assets | 144.98M | 211.39M | 136.59M | 178.56M | 114.51M | 101.73M | 73.16M | 85.51M | 36.45M | 60.54M | 3.91M |
Property-Plant & Equipment | 19.48M | 24.66M | 27.29M | 29.64M | 31.89M | 3.86M | 3.94M | 4.85M | 4.80M | 881.00K | 938.00K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 23.19M | 33.09M | 46.35M | 34.69M | 35.47M | 5.03M | 5.33M | 5.82M | 7.18M | 951.00K | 1.01M |
Total Assets | 168.17M | 244.49M | 182.94M | 213.25M | 149.98M | 106.77M | 78.49M | 91.32M | 43.63M | 61.49M | 4.92M |
Account Payables | 11.54M | 6.41M | 3.69M | 3.60M | 5.85M | 3.31M | 2.28M | 2.42M | 5.04M | 928.00K | 594.00K |
Deferred Revenue | n/a | 4.33M | 10.18M | 12.21M | 5.74M | 1.93M | 355.00K | 550.00K | n/a | n/a | n/a |
Short-Term Debt | 8.99M | 4.14M | 4.02M | 3.46M | 2.56M | 18.00K | 94.00K | 336.00K | 133.00K | n/a | n/a |
Other Current Liabilities | 16.15M | 15.89M | 13.61M | 9.36M | 9.37M | 14.28M | 10.04M | 6.27M | 2.79M | 324.00K | 316.00K |
Total Current Liabilities | 36.68M | 30.78M | 31.51M | 28.62M | 23.52M | 19.53M | 12.41M | 9.57M | 7.96M | 1.25M | 910.00K |
Long-Term Debt | 53.08M | 61.50M | 63.18M | 64.48M | 24.64M | 22.00K | 6.00K | 53.00K | 206.00K | n/a | n/a |
Other Long-Term Liabilities | 61.75M | 24.47M | 3.03M | 19.71M | n/a | 353.00K | 745.00K | 1.10M | 1.42M | 1K | n/a |
Total Long-Term Liabilities | 114.83M | 85.97M | 66.21M | 94.07M | 47.28M | 8.65M | 751.00K | 1.15M | 1.63M | 1K | n/a |
Total Liabilities | 151.51M | 116.75M | 97.72M | 122.70M | 70.79M | 28.18M | 13.16M | 10.72M | 9.58M | 1.25M | 910.00K |
Total Debt | 62.08M | 63.57M | 65.19M | 66.21M | 25.92M | 31.00K | 53.00K | 221.00K | 339.00K | n/a | n/a |
Common Stock | 26.00K | 20.00K | 61.00K | 56.00K | 43.00K | 34.00K | 26.00K | 23.00K | 2.00K | 1K | 5.00K |
Retained Earnings | -722.81M | -558.23M | -463.58M | -377.02M | -292.98M | -217.54M | -155.27M | -101.26M | -53.51M | -23.70M | -10.26M |
Comprehensive Income | n/a | 102.00K | -79.00K | 0.00 | 24.00K | -3.00K | -42.00K | -9.00K | -931.00K | -428.00K | n/a |
Shareholders Equity | 16.66M | 127.74M | 85.22M | 90.55M | 79.18M | 78.59M | 65.32M | 80.60M | 34.05M | 60.24M | 3.97M |
Total Investments | 2.12M | 34.84M | 51.10M | 3.09M | 49.98M | 49.79M | 39.84M | 25.00M | 483.00K | n/a | n/a |